Jenner Institute

The Jenner Institute
Parent institutionUniversity of Oxford
EstablishedNovember 2005; 19 years ago (2005-11)
DirectorAdrian Hill
Staff100
Key peopleSarah Gilbert[1]
Helen McShane
Formerly calledEdward Jenner Institute for Vaccine Research
AddressOld Road Campus Research Building (ORCRB), Roosevelt Drive, Oxford OX3 7DQ, UK
Location
Old Road Campus Research Building
,
Oxford
,
United Kingdom
Coordinates51°45′07″N 1°12′59″W / 51.7519293°N 1.2163045°W / 51.7519293; -1.2163045
Websitewww.jenner.ac.uk Edit this at Wikidata

The Jenner Institute is a research institute on the Old Road Campus in Headington, east Oxford, England. It was formed in November 2005 through a partnership between the University of Oxford and the UK Institute for Animal Health.[2] It is associated with the Nuffield Department of Medicine, in the Medical Sciences Division of Oxford University. The institute receives charitable support from the Jenner Vaccine Foundation.[3][4]

The institute is led by Prof. Adrian Hill.[5] The institute develops vaccines and carries out clinical trials for diseases including malaria, tuberculosis (vaccine MVA85A), ebola, and MERS-Coronavirus.[6][7]

In 2020, the institute successfully developed the Oxford–AstraZeneca COVID-19 vaccine, in a project backed by private companies including Oxford Sciences Innovation, Google Ventures, and Sequoia Capital, among others.[8] When developed, the UK government backed trials, purchased 100 million doses, and encouraged Oxford to work with AstraZeneca, a company based in Europe, instead of Merck & Co., a US-based company; while the US gave US$1.2bn of government funding in return for 300 million doses.[9][10] It collaborated with Italy's Advent Srl (part of the IRBM Group) on the development[11] and Germany's Merck Group on the manufacture of the COVID-19 vaccine.[3] Vaccinologist Dame Sarah Gilbert was one of the leading scientists involved in the development.[1][12]

The institute is named after the English physician and immunization pioneer Edward Jenner (1749–1823), who was a major contributor to the development of the smallpox vaccine.[citation needed]

  1. ^ a b Lane, Richard (2020). "Sarah Gilbert: carving a path towards a COVID-19 vaccine". The Lancet. 395 (10232): 1247. doi:10.1016/S0140-6736(20)30796-0. PMC 7162644. PMID 32305089.
  2. ^ "The Jenner Institute". Health Check. UK: Nuffield Department of Medicine, University of Oxford. Archived from the original on 27 May 2020. Retrieved 17 April 2020.
  3. ^ a b "Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing" (Press release). Merck Group. Retrieved 17 April 2020.
  4. ^ Jenner Institute on Twitter
  5. ^ "Preparing for Future Epidemics". Health Check. UK: BBC. 10 June 2015. Retrieved 17 April 2020.
  6. ^ "Ebola vaccine trial begins". BBC News. 17 September 2014.
  7. ^ "Helen McShane". ndm.ox.ac.uk.
  8. ^ "The Backstory: Vaccitech and its role in co-inventing the Oxford COVID-19 vaccine". Oxford Sciences Innovation. 23 November 2020. Archived from the original on 1 May 2021. Retrieved 25 March 2021.
  9. ^ "The Oxford vaccine: the trials and tribulations of a world-saving jab". The Guardian. 26 June 2021. Archived from the original on 27 June 2021. Retrieved 27 June 2021.
  10. ^ Keown C. "U.S. gives AstraZeneca $1.2 billion to fund Oxford University coronavirus vaccine — America would get 300 million doses beginning in October". MarketWatch. Archived from the original on 26 January 2021. Retrieved 30 March 2021.
  11. ^ "The Jenner Institute signs an agreement with Advent to develop a novel coronavirus vaccine". IRBM. Archived from the original on 19 January 2021. Retrieved 18 April 2020.
  12. ^ "Prof Sarah Gilbert: Coronavirus vaccine trials to start within days". The Andrew Marr Show. UK: BBC One. 19 April 2020. Retrieved 19 April 2020.